Page last updated: 2024-08-05 10:43:00
dihydronaphthalenes
Any carbobycyclic compound that is a dihydronaphthalene or a compound obtained from a dihydronaphthalene by formal substitution of one or more hydrogens.
ChEBI ID: 90740
Members (3)
| Member | Definition | Role |
|---|---|---|
| 1,2-dihydroxy-1,2-dihydronaphthalene | A member of the class of naphthalenediols that is 1,2-dihydronaphthalene substituted by hydroxy groups at positions 1 and 2 respectively. | 1,2-dihydronaphthalene-1,2-diol |
| bms 204493 | A member of the class of dihydronaphthalenes that is 1,2-dihydronaphthalene which is substituted at positions 1, 1, 4, and 6 by methyl, methyl, phenylethynyl, and 2-(p-carboxyphenyl)vinyl groups, respectively (the E isomer). | BMS-493 |
| bms453 | A member of the class of dihydronaphthalenes that is 1,2-dihydronaphthalene which is substituted at positions 1, 1, 4, and 6 by methyl, methyl, phenyl, and 2-(p-carboxyphenyl)vinyl groups, respectively (the E isomer). It is a potent retinoic acid receptor gamma (RARbeta) agonist that acts as an antagonist against RARalpha and RARgamma. | BMS-453 |
Research
Studies (44)
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (4.55) | 18.7374 |
| 1990's | 6 (13.64) | 18.2507 |
| 2000's | 15 (34.09) | 29.6817 |
| 2010's | 14 (31.82) | 24.3611 |
| 2020's | 7 (15.91) | 2.80 |
Study Types
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (2.13%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 46 (97.87%) | 84.16% |